Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CMS Pays Out $2.5 Billion In Electronic Health Record Incentives In 2011

This article was originally published in The Pink Sheet Daily

Executive Summary

The HHS Office of the National Coordinator for Health Information Technology expects adoption and meaningful use to continue to grow in 2012 as it prepares to address recommendations from a November IoM report.

You may also be interested in...

CMS Finalizes Stage 2 Standards For Electronic Health Records With Delayed Implementation

Agency gives eligible physicians and hospitals that started earning incentive payments for the meaningful use of electronic health records in 2011 an additional year, until 2014, to begin demonstrating that they are meeting the standards outlined in the recently finalized rule.

Adverse Event Reporting Included In Draft Electronic Health Record Standards

A draft proposal for stage 3 of standards that health care professionals must meet to demonstrate meaningful use of electronic health records includes an adverse event reporting requirement. Janet Woodcock has highlighted adverse event reporting as an area where the agency hopes to interface with EHRs.

Linking EHRs To Cancer Registries Good In Theory, But Difficult In Practice, ASCO Says

The American Society of Clinical Oncology offers support for the notion of using electronic health records to help provide information to cancer registries, but is critical of CMS’ approach as outlined in the stage 2 meaningful use proposed rule.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts